Skip to main content
RX

RxCell

Singapore, Singapore
Last funding
$4.6M
Series ADec 2023

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

Backed byRegenosisDMR Global Venture

About RxCell

How much funding has RxCell raised?

RxCell has raised $4.6M in total funding. The most recent round was Series A. The last funding was announced in December 2023.

Who are RxCell's investors?

RxCell's investors include Regenosis, DMR Global Venture.

Where is RxCell headquartered?

RxCell is headquartered in Singapore, Singapore.

What does RxCell do?

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

What stage is RxCell at?

RxCell is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"RxCell — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/rxcell. Accessed November 20, 2026.
APA
VCBacked. (2023). RxCell — Funding & Investors. Retrieved November 20, 2026, from https://www.vcbacked.co/company/rxcell
Wikipedia (cite web)
{{cite web |title=RxCell — Funding & Investors |url=https://www.vcbacked.co/company/rxcell |website=VCBacked |access-date=November 20, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at RxCell? Request a listing update

Founder contacts
m***@rxcellinc.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →